Мальта - английский - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - carbidopa, levodopa - tablet - carbidopa 10.8 milligram(s) ; levodopa 100 milligram(s) - anti-parkinson drugs

Канада - английский - Health Canada

merck canada inc - levodopa; carbidopa - tablet - 100mg; 10mg - levodopa 100mg; carbidopa 10mg - dopamine precursors

Канада - английский - Health Canada

organon canada inc. - carbidopa; levodopa - tablet - 25mg; 100mg - carbidopa 25mg; levodopa 100mg - dopamine precursors

Ирландия - английский - HPRA (Health Products Regulatory Authority)

b & s healthcare - levodopa carbidopa - tablets - 25/100 milligram

Австралия - английский - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - carbidopa monohydrate, quantity: 27 mg (equivalent: carbidopa, qty 25 mg); levodopa, quantity: 250 mg - tablet, uncoated - excipient ingredients: indigo blue; maize starch; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch - sinemet is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinemet frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with parkinson's disease and syndrome.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - carbidopa monohydrate, quantity: 54 mg (equivalent: carbidopa, qty 50 mg); levodopa, quantity: 200 mg - tablet, modified release - excipient ingredients: indigo carmine; hypromellose; hyprolose; allura red ac; magnesium stearate - idiopathic parkinsonism, where standard formulations containing levodopa/carbidopa have produced inadequate control. experience is limited with sinemet cr in patients who have not been treated with levodopa before.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg; levodopa 100mg; carbidopa monohydrate 27mg equivalent to carbidopa 25 mg; levodopa 100mg; carbidopa monohydrate 27mg equivalent to carbidopa 25 mg; levodopa 100mg - tablet - 25/100 - active: carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg levodopa 100mg excipient: crotonic acid-polyvinylacetate copolymer magnesium stearate maize starch microcrystalline cellulose purified water quinoline yellow starch active: carbidopa monohydrate 27mg equivalent to carbidopa 25 mg levodopa 100mg excipient: crospovidone hyprolose magnesium stearate microcrystalline cellulose pregelatinised maize starch quinoline yellow active: carbidopa monohydrate 27mg equivalent to carbidopa 25 mg levodopa 100mg excipient: magnesium stearate maize starch microcrystalline cellulose quinoline yellow starch - sinemet is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinemet frequently is helpful in the management of tremor, dysphagia, sialorrhoea, and postural instability associated with parkinson's disease and syndrome. when therapeutic response to levodopa alone is irregular, and signs and symptoms of parkinson's disease are not evenly controlled throughout the day, substitution of sinemet usually is effective in reducing fluctuations in response. by reducing certain adverse reactions produced by levodopa alone, sinemet permits more patients to obtain adequate relief of the symptoms of parkinson's disease. sinemet is also indicated for patients with parkinsonism who are taking vitamin preparations that contain pyridoxine hydrochloride (vitamin b6).

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg; levodopa 250mg; carbidopa monohydrate 27mg equivalent to carbidopa 25 mg; levodopa 250mg; carbidopa monohydrate 27mg equivalent to carbidopa 25 mg; levodopa 250mg - tablet - 25/250 - active: carbidopa monohydrate 26.9mg equivalent to carbidopa 25 mg levodopa 250mg excipient: indigo carmine crotonic acid - polyvinylacetate copolymer magnesium stearate microcrystalline cellulose starch   active: carbidopa monohydrate 27mg equivalent to carbidopa 25 mg levodopa 250mg excipient: crospovidone hyprolose indigo carmine magnesium stearate microcrystalline cellulose pregelatinised maize starch active: carbidopa monohydrate 27mg equivalent to carbidopa 25 mg levodopa 250mg excipient: indigo carmine magnesium stearate maize starch microcrystalline cellulose starch - sinemet is indicated for the treatment of parkinson's disease and syndrome. it is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. sinemet frequently is helpful in the management of tremor, dysphagia, sialorrhoea, and postural instability associated with parkinson's disease and syndrome. when therapeutic response to levodopa alone is irregular, and signs and symptoms of parkinson's disease are not evenly controlled throughout the day, substitution of sinemet usually is effective in reducing fluctuations in response. by reducing certain adverse reactions produced by levodopa alone, sinemet permits more patients to obtain adequate relief of the symptoms of parkinson's disease. sinemet is also indicated for patients with parkinsonism who are taking vitamin preparations that contain pyridoxine hydrochloride (vitamin b6).

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - tolcapone 100mg - film coated tablet - 100 mg - active: tolcapone 100mg excipient: calcium hydrogen phosphate ethylcellulose hypromellose iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc   sodium laurilsulfate sodium starch glycolate titanium dioxide triacetin - tasmar is indicated for use in combination with levodopa/benserazide and levodopa/carbidopa in parkinson's disease, including both fluctuating and non-fluctuating patients.

Ирландия - английский - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - carbidopa levodopa - tablets - 10/100 milligram